Barclays’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-600
| Closed | -$18K | – | 3828 |
|
|
2021
Q3 | $18K | Sell |
600
-386
| -39% | -$11.6K | ﹤0.01% | 3661 |
|
|
2021
Q2 | $45K | Sell |
986
-1,998
| -67% | -$91.2K | ﹤0.01% | 3434 |
|
|
2021
Q1 | $178K | Buy |
2,984
+1,817
| +156% | +$108K | ﹤0.01% | 3170 |
|
|
2020
Q4 | $61K | Sell |
1,167
-447
| -28% | -$23.4K | ﹤0.01% | 3117 |
|
|
2020
Q3 | $55K | Sell |
1,614
-239
| -13% | -$8.14K | ﹤0.01% | 3248 |
|
|
2020
Q2 | $160K | Buy |
1,853
+902
| +95% | +$77.9K | ﹤0.01% | 2919 |
|
|
2020
Q1 | $56K | Sell |
951
-1,984
| -68% | -$117K | ﹤0.01% | 3052 |
|
|
2019
Q4 | $212K | Buy |
2,935
+1,538
| +110% | +$111K | ﹤0.01% | 3151 |
|
|
2019
Q3 | $85K | Sell |
1,397
-1,205
| -46% | -$73.3K | ﹤0.01% | 3482 |
|
|
2019
Q2 | $247K | Buy |
2,602
+459
| +21% | +$43.6K | ﹤0.01% | 3090 |
|
|
2019
Q1 | $174K | Buy |
2,143
+2,003
| +1,431% | +$163K | ﹤0.01% | 3091 |
|
|
2018
Q4 | $23K | Sell |
140
-73
| -34% | -$12K | ﹤0.01% | 3352 |
|
|
2018
Q3 | $35K | Buy |
213
+56
| +36% | +$9.2K | ﹤0.01% | 3834 |
|
|
2018
Q2 | $24K | Buy |
+157
| New | +$24K | ﹤0.01% | 3557 |
|